Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrent Uterine Corpus Sarcoma × Filgrastim × Clear all

Sponsor

Conditions

Lymphoma 58 Multiple Myeloma 52 Leukemia 47 Leukemia, Myeloid, Acute 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Myelodysplastic Syndromes 36 Lymphoma, Non-Hodgkin 36 Hodgkin Disease 35 Lymphoma, Mantle-Cell 26 Lymphoma, Large B-Cell, Diffuse 26 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Follicular 22 Breast Neoplasms 22 Burkitt Lymphoma 21 Lymphoma, B-Cell, Marginal Zone 16 Congenital Abnormalities 15 Lymphoma, Large-Cell, Immunoblastic 14 Recurrence 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13 Sarcoma 12 Neoplasms, Plasma Cell 12 Hematologic Neoplasms 10 Leukemia, Myelomonocytic, Juvenile 9 Leukemia, Biphenotypic, Acute 9 Blast Crisis 9 Neoplasms 8 Leukemia, Myelomonocytic, Chronic 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroblastoma 7 Myeloproliferative Disorders 7

Interventions

pazopanib 1 ixabepilone 1 Gemcitabine 1 Epothilones 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡